소화기 내시경 시술 전후 항혈전제 사용 임상진료지침: 2023 IDEN 합의

• Published in: The Korean journal of gastroenterology Vol. 83; no. 6; pp. 217 - 232
• Main Authors: 강승주, Seung Joo Kang, 태정현, Chung Hyun Tae, 방창석, Chang Seok Bang, 신철민, Cheol Min Shin, 정영훈, Young-hoon Jeong, 최미영, Miyoung Choi, 황주하, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, 최기돈, Kee Don Choi, 심기남, Ki-nam Shim, 송근암, Geun Am Song, 이오영, Oh Young Lee
• Format: Journal Article
• Language: Korean
• Published: 대한소화기학회 30.06.2024
• Subjects: Anticoagulants; Endoscopy; Guideline; Platelet aggregation inhibitors; 내과학
• ISSN: 1598-9992; 2233-6869
• DOI: 10.4166/kjg.2024.040

Antithrombotic agents, including antiplatelet agent and anticoagulants are widely used in Korea due to increasing incidence of cardio-cerebrovascular disease and aging population. The management of patients using antithrombotic agents during endoscopic procedures is an important clinical challenge. Clinical practice guideline regarding this issue which was developed by the Korean Society of Gastrointestinal Endoscopy was published in 2020. However, since then, new evidence has emerged for the use of dual antiplatelet therapy and direct anticoagulant management, and revised guidelines were issued in the US and Europe. Accordingly, the previous guidelines were revised, cardiologists also participated in the development group, and the recommendations went through a consensus process among international experts. This guideline presents 14 recommendations made according to the Grading of Recommendations, Assessment, Development, and Evaluation methodology, and was reviewed by multidisciplinary experts. This guideline provides useful information that can assist endoscopists in the management of patients on antithrombotic agents who require diagnostic and elective therapeutic endoscopy. It will be revised as necessary to cover changes in technology, evidence, or other aspects of clinical practice. (Korean J Gastroenterol 2024;83:217-232)